loading
Lipella Pharmaceuticals Inc stock is traded at $2.53, with a volume of 133.11K. It is up +2.07% in the last 24 hours and down -37.19% over the past month. Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.
See More
Previous Close:
$2.41
Open:
$2.42
24h Volume:
133.11K
Relative Volume:
0.82
Market Cap:
$2.94M
Revenue:
-
Net Income/Loss:
$-4.74M
P/E Ratio:
-3.9067
EPS:
-0.6476
Net Cash Flow:
$-3.46M
1W Performance:
-2.38%
1M Performance:
-37.19%
6M Performance:
-57.77%
1Y Performance:
-73.26%
1-Day Range:
Value
$2.42
$2.75
1-Week Range:
Value
$2.21
$2.75
52-Week Range:
Value
$2.21
$12.00

Lipella Pharmaceuticals Inc Stock (LIPO) Company Profile

Name
Name
Lipella Pharmaceuticals Inc
Name
Phone
412-901-0315
Name
Address
400 N LEXINGTON ST, PITTSBURGH
Name
Employee
7
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
LIPO's Discussions on Twitter

Compare LIPO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
LIPO 2.54 2.94M 0 -4.74M -3.46M -0.6476
VRTX 446.37 115.74B 10.63B -479.80M -1.35B 13.33
REGN 740.39 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 592.20 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.97 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.80 24.49B 3.30B -501.07M 1.03B 11.54

Lipella Pharmaceuticals Inc Stock (LIPO) Latest News

pulisher
05:32 AM

Lipella Pharmaceuticals Announces Completion of First - GlobeNewswire

05:32 AM
pulisher
05:30 AM

Lipella's LP-310 OLP Treatment Advances in Phase 2a Trial with Promising Safety Data | LIPO Stock News - StockTitan

05:30 AM
pulisher
Nov 20, 2024

Lipella Pharmaceuticals Faces Nasdaq Delisting Risk Amid Compliance Challenges - MSN

Nov 20, 2024
pulisher
Nov 17, 2024

Lipella Pharmaceuticals Third Quarter 2024 Earnings: US$1.29 loss per share (vs US$1.84 loss in 3Q 2023) - Yahoo Finance

Nov 17, 2024
pulisher
Nov 15, 2024

LIPO stock touches 52-week low at $2.21 amid market challenges - Investing.com

Nov 15, 2024
pulisher
Nov 15, 2024

Lipella Pharmaceuticals Inc (LIPO) Quarterly 10-Q Report - Quartz

Nov 15, 2024
pulisher
Nov 14, 2024

Lipella Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024
pulisher
Nov 12, 2024

Lipella issued patent by USPTO for liposomal drug delivery platform - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Lipella Pharmaceuticals Secures Extended Market Exclusivity with Issuance of U.S. Patent for Liposomal Delivery Platform - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Lipella Pharmaceuticals Secures Extended Market Exclusivity - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

Lipella Pharma Secures Key Patent for Liposomal Platform, Extends Drug Pipeline Protection to 2035 | LIPO Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 11, 2024

China chip index nears 3-year high as TSMC order fuels self-reliance bets - Investing.com

Nov 11, 2024
pulisher
Nov 08, 2024

Cathay general bancorp vice chairman sells $2.11 million in stock - Investing.com

Nov 08, 2024
pulisher
Nov 06, 2024

Contrasting Wellness Center USA (OTCMKTS:WCUI) & Lipella Pharmaceuticals (NASDAQ:LIPO) - Defense World

Nov 06, 2024
pulisher
Nov 05, 2024

Lipella Pharmaceuticals stock hits 52-week low at $0.32 - Investing.com India

Nov 05, 2024
pulisher
Nov 05, 2024

Lipella Pharmaceuticals stock hits 52-week low at $0.32 By Investing.com - Investing.com Australia

Nov 05, 2024
pulisher
Nov 03, 2024

Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split - citybiz

Nov 03, 2024
pulisher
Nov 01, 2024

Lipella Pharmaceuticals Launching 1-for-8 Reverse Stock Split - Marketscreener.com

Nov 01, 2024
pulisher
Nov 01, 2024

Lipella Pharmaceuticals announces 1-for-8 reverse stock split - MSN

Nov 01, 2024
pulisher
Nov 01, 2024

Lipella Pharmaceuticals announces 1-for-8 reverse stock split By Investing.com - Investing.com UK

Nov 01, 2024
pulisher
Oct 29, 2024

Lipella Pharmaceuticals to Present at 2024 Spartan Capital Investor Conference - GlobeNewswire

Oct 29, 2024
pulisher
Oct 19, 2024

Lipella Pharmaceuticals faces Nasdaq delisting over equity shortfall - Investing.com India

Oct 19, 2024
pulisher
Oct 18, 2024

Lipella Pharmaceuticals faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com South Africa

Oct 18, 2024
pulisher
Oct 18, 2024

Biotech Alert: Searches spiking for these stocks today - TipRanks

Oct 18, 2024
pulisher
Oct 16, 2024

Ocugen Inc (OCGN) rating initates by Maxim Group - Knox Daily

Oct 16, 2024
pulisher
Oct 16, 2024

Potential Price Increase for First Advantage Corp. (FA) After Recent Insider Activity - Knox Daily

Oct 16, 2024
pulisher
Oct 16, 2024

Lipella Pharmaceuticals Inc (LIPO) Becoming More Attractive for Investors - Knox Daily

Oct 16, 2024
pulisher
Oct 16, 2024

Recent Insider Activity Suggests Potential Gains for KE Holdings Inc ADR (BEKE) - Knox Daily

Oct 16, 2024
pulisher
Oct 16, 2024

Lipella Pharmaceuticals Inc [LIPO] is -57.84% lower this YTD. Is it still time to buy? - The DBT News

Oct 16, 2024
pulisher
Oct 15, 2024

Allovir (ALVR) Stock Experiences Significant Decline Amid Negati - GuruFocus.com

Oct 15, 2024
pulisher
Oct 15, 2024

Huge semiconductor deal has eyes on this tech co 👀 - RagingBull

Oct 15, 2024
pulisher
Oct 15, 2024

Lipella Pharmaceuticals Announces U.S. Patent Allowance for Innovative Liposomal Drug Delivery Platform - GlobeNewswire

Oct 15, 2024
pulisher
Oct 13, 2024

Interstitial Cystitis Market Size is Set for Rapid Growth as - openPR

Oct 13, 2024
pulisher
Oct 09, 2024

Sky Quarry Announces Closing of Public Offering of $6.7 Million - The Manila Times

Oct 09, 2024
pulisher
Oct 09, 2024

TSX 60 Shariah Index (TXSI) QuotePress Release - The Globe and Mail

Oct 09, 2024
pulisher
Oct 09, 2024

Lipella Pharmaceuticals to Present at 2024 Maxim Healthcare Virtual Summit - GlobeNewswire

Oct 09, 2024
pulisher
Sep 30, 2024

Expion360 Inc’s latest rating changes from various analysts - Knox Daily

Sep 30, 2024
pulisher
Sep 26, 2024

Insider Buying: Kaufman Jonathan H, Lipella Pharmaceuticals Inc [LIPO] insider invested 10,000 shares - Knox Daily

Sep 26, 2024
pulisher
Sep 26, 2024

The time has not yet come to remove your chips from the table: Lipella Pharmaceuticals Inc (LIPO) - SETE News

Sep 26, 2024
pulisher
Sep 25, 2024

Lipella Pharmaceuticals Inc Inc. (LIPO) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle

Sep 25, 2024
pulisher
Sep 25, 2024

PRISM MarketView Features Q&A with Dr. Michael Chancellor: - GlobeNewswire

Sep 25, 2024
pulisher
Sep 25, 2024

PRISM MarketView Features Q&A with Dr. Michael Chancellor: Lipella Pharmaceuticals Advances Innovative Treatments for Hemorrhagic Cystitis During Urology Awareness Month - Morningstar

Sep 25, 2024
pulisher
Sep 24, 2024

Lipella reports positive phase 2a trial results for OLP treatment - Investing.com

Sep 24, 2024
pulisher
Sep 24, 2024

Lipella Pharmaceuticals Reports Encouraging Early - GlobeNewswire

Sep 24, 2024
pulisher
Sep 24, 2024

Lipella Pharmaceuticals Reports Encouraging Early Tolerability Results in Phase 2a Trial of LP-310 for Oral Lichen Planus - StockTitan

Sep 24, 2024
pulisher
Sep 23, 2024

A year in review: Lipella Pharmaceuticals Inc (LIPO)’s performance in the last year - US Post News

Sep 23, 2024
pulisher
Sep 23, 2024

Lipella Pharmaceuticals Inc’s Market Journey: Closing Weak at 0.41, Down -2.35 - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Lipella stock soars 200% on Phase 2 study initiation - MSN

Sep 23, 2024
pulisher
Sep 19, 2024

Matthew E Korenberg At Ligand Pharmaceuticals Executes Options Exercise, Realizing $260K - Benzinga

Sep 19, 2024
pulisher
Sep 19, 2024

Pliant Therapeutics (NASDAQ:PLRX) Sees Strong Trading Volume - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

John Deneen Collins Sells 85,126 Shares of LivePerson, Inc. (NASDAQ:LPSN) Stock - Defense World

Sep 19, 2024

Lipella Pharmaceuticals Inc Stock (LIPO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Cap:     |  Volume (24h):